P030: Baseline IgM amount can identify patients with adverse outcome despite a PET-2 adapted treatment in classical Hodgkin Lymphoma: results from a real-life single-center study i

• Alessandra Romano,
• Claudio Cerchione,
• Gabriella Santuccio,
• Marialudovica Le Moli,
• Annalisa Chiarenza,
• Amalia Figuera,
• Giovanna Motta,
• L. Caruso,
• Sofia Lanza,
• A. Petronaci,
• S. Poidomani,
• Massimo Ippolito,
• Francesco Di Raimondo

Affiliations

Alessandra Romano

1 Università degli Studi di Catania

Claudio Cerchione

2 IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” - IRST S.r.l.

Gabriella Santuccio

3 Department of general Surgery and Medical-Surgical Specialties, Haematology section, University of Catania, Italy

Marialudovica Le Moli

3 Department of general Surgery and Medical-Surgical Specialties, Haematology section, University of Catania, Italy

Annalisa Chiarenza

3 Department of general Surgery and Medical-Surgical Specialties, Haematology section, University of Catania, Italy

Amalia Figuera

3 Department of general Surgery and Medical-Surgical Specialties, Haematology section, University of Catania, Italy

Giovanna Motta

3 Department of general Surgery and Medical-Surgical Specialties, Haematology section, University of Catania, Italy

L. Caruso

3 Department of general Surgery and Medical-Surgical Specialties, Haematology section, University of Catania, Italy

Sofia Lanza

3 Department of general Surgery and Medical-Surgical Specialties, Haematology section, University of Catania, Italy

A. Petronaci

3 Department of general Surgery and Medical-Surgical Specialties, Haematology section, University of Catania, Italy

S. Poidomani

3 Department of general Surgery and Medical-Surgical Specialties, Haematology section, University of Catania, Italy

Massimo Ippolito

4 Nuclear Medicine Center, Azienda Ospedaliera Cannizzaro, Catania, Italy

Francesco Di Raimondo

3 Department of general Surgery and Medical-Surgical Specialties, Haematology section, University of Catania, Italy